Last Updated: August 9, 2026

Sagent Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS INC

SAGENT PHARMS INC has fifty-five approved drugs.

Summary for Sagent Pharms Inc

US Patents:	0
Tradenames:	47
Ingredients:	46
NDAs:	55

Drugs and US Patents for Sagent Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms Inc	CISATRACURIUM BESYLATE	cisatracurium besylate	INJECTABLE;INJECTION	201851-001	Nov 6, 2020	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	PIPERACILLIN AND TAZOBACTAM	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	208674-003	Feb 16, 2021	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	CLINDAMYCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	090109-001	Sep 30, 2011	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	DAPTOMYCIN	daptomycin	POWDER;INTRAVENOUS	207104-001	Nov 15, 2019	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	METHYLPREDNISOLONE ACETATE	methylprednisolone acetate	INJECTABLE;INJECTION	201835-001	Jun 27, 2018		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	209967-001	Jan 16, 2020	AP1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	091065-001	Nov 27, 2013	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.